[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349103-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349103-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","engineering-nk-and-t-cells-with-metabolite-sensing-receptors-to-target-solid-tumors","Engineering NK and T cells with Metabolite-sensing Receptors to Target Solid Tumors","","Natural killer (NK) and T cells must infiltrate solid tumors to eradicate them, yet effective recruitment into tumor sites remains limited. This study develops programmable strategies to mobilize NK and T cells using metabolite-sensing receptors. In vivo and in vitro CRISPR activation screens nominate GPR183, GPR84, GPR34 and GPR18 as enhancers of infiltration and chemotaxis in breast and ovarian cancers. Ligand-dependent receptor expression rewires migration programs and can improve tumor control in CAR NK and T-cell models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/engineering-nk-and-t-cells-with-metabolite-sensing-receptors-to-target-solid-tumors/349103/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/engineering-nk-and-t-cells-with-metabolite-sensing-receptors-to-target-solid-tumors/349103.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is engineering NK and T cells necessary for solid tumor therapy?","Question",{"text":63,"@type":64},"NK and T cells must infiltrate solid tumors to eliminate them, but insufficient recruitment and infiltration limits immunotherapy and cell therapy efficacy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which metabolite-sensing receptors were identified as top enhancers of infiltration and chemotaxis?",{"text":68,"@type":64},"CRISPR activation screens using NK-92 cells highlighted GPR183, GPR84, GPR34 and GPR18 as top enhancers of infiltration and chemotaxis to breast and ovarian cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"How does receptor expression affect immune cell behavior in this study?",{"text":72,"@type":64},"Expressing these receptors in NK and T cells drives migration toward cancer-cell-released factors and alters NK cell transcription in a ligand-dependent manner.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349103,1790269619,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","nature immunology  \nArticle [https://doi.org/10.1038/s41590-026-02473-y](https://doi.org/10.1038/s41590-026-02473-y)  \nEngineering NK and T cells with metabolite-sensing receptors to target solid tumors  \nReceived: 9 March 2025  \nAccepted: 18 February 2026  \n\n| Published online: 23 March 2026 |\n| --- |\n|  Check for updates |\n\nYoung-Min Kim1, Min K. Tsai1,2, Chang Sun  1, Olivia Laveroni  1, Reece VillarinAkana1,2, Kristen Frombach1,2 & Livnat Jerby  1,2,3,4   \nNatural killer (NK) cells and T cells need to infiltrate solid tumors to eradicate them. Here we show programmable mechanisms that can mobilize NK and T cells to solid tumors using metabolite-sensing receptors. In vivo and in vitro CRISPR activation screens using NK-92 cells identified GPR183, GPR84, GPR34 and GPR18 as top enhancers of infiltration and chemotaxis to breast and ovarian cancers. While endogenously expressed in restricted cellular contexts, expressing these receptors inNKandT cells drives migration to factors released by cancer cells and alters theNK cell transcriptome ina ligand-dependent manner. Expressing GPR183 inNK, chimeric antigen receptor (CAR) NK and CART cells increased tumor infiltration and control. Likewise, expressing GPR183 in mouse T cells increased tumor eradication in immunocompetent mice. These data show that metabolite sensing can be rewired to obtain biochemically guided spatially targeted cells, creating new possibilities for therapeutic intervention.  \nMapping the logic of immune cell migration and identifying mechanismsto redirect immune cells to specific sites in the body and within a target tissue are critical objectives, asthe location of immune cells dictates whether and how these cells elicit their effects. Although immunotherapies and cell therapies can be exceptionally effective1, insufficient recruitment and infiltration of cytotoxic lymphocytes to solid tumors still limit the efficacy of these treatments2,3, underscoring the need and potential of ‘cell delivery’ solutions.  \nImmune cell migration and infiltration rely on chemical, mechanical and electrical signals4. The main genes thought to orchestrate immune cell recruitment to solid tumors are chemokines and their cognate receptors expressed by immune cells, as well as adhesion proteins, such as selectinsand integrins, that mediate transmigration and infiltration5,6. Yet, while these protein–protein interactions have been extensively studied, our ability to mobilize immune cells to specific sites and into solid tumors remains limited.  \nForward genetic screens offer a powerful framework to optimize different cell functions of interest via directed evolution, such that genetic variation is induced (for example, via CRISPR or other tools) and a pool of genetically modified cells undergoes selection to identify the cells that are optimal at performing a ‘task’ of interest. Gain-of-function screens are particularly useful for studying and leveraging gene functions outside of their endogenous cellular contexts. Yet, while CRISPR knockout7,8, interference and activation9 as well as open reading frame (ORF)10 and short hairpin RNA11 screens have been performed to study immune cell functions, to date, gain-of-function screens have not been used to study tumor infiltration.  \nHere, wereport programmable mechanisms to mobilize cytotoxic lymphocytes to solid tumors based on the activation of metabolitesensing and orphan G-protein-coupled receptors (GPCRs), identified inan array of in vivo and in vitro gain-of-function screens. As we show,  \n1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. 2Cancer Biology Program, Stanford University, Stanford, CA, USA. 3Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. 4Chan Zuckerberg Biohub, San Francisco, CA, USA. e-mail: [ljerby@stanford.edu](ljerby@stanford.edu)  \nNature Immunology | Volume 27 | May 2026 |1039–1052 1039  \nthis information can be used to design more efficacio","cbCaitmRB5BTCBUS","https://ap.wps.com/l/cbCaitmRB5BTCBUS","pdf",11035434,38,"English","# Results\n## Metabolite-sensing GPCRs are tumor infiltration enhancers","[{\"question\":\"Why is engineering NK and T cells necessary for solid tumor therapy?\",\"answer\":\"NK and T cells must infiltrate solid tumors to eliminate them, but insufficient recruitment and infiltration limits immunotherapy and cell therapy efficacy.\"},{\"question\":\"Which metabolite-sensing receptors were identified as top enhancers of infiltration and chemotaxis?\",\"answer\":\"CRISPR activation screens using NK-92 cells highlighted GPR183, GPR84, GPR34 and GPR18 as top enhancers of infiltration and chemotaxis to breast and ovarian cancers.\"},{\"question\":\"How does receptor expression affect immune cell behavior in this study?\",\"answer\":\"Expressing these receptors in NK and T cells drives migration toward cancer-cell-released factors and alters NK cell transcription in a ligand-dependent manner.\"}]","Engineering NK and T cells with Metabolite-sensing Receptors to Target Solid Tumors | PDF",1790081650,96,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/494c8a3a2832050c6c53bdd017de1ea2.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68ce7d7e73d781a9475a686d244a9f9a.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c386044a9033634a918525c4dcb56565.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7b5f29405881ad2ef017533ab4d8d6a.webp",980,1301]